Abstract | OBJECTIVE: METHODS: PubMed, Web of Science, Scopus and EBSCOhost were searched for relevant randomized controlled trials published until September 2013. RESULTS:
Carbetocin was associated with a significantly reduced need for additional uterotonic agents (RR = 0.68, 95% CI: 0.55-0.84, I(2 )= 4%) compared with oxytocin in women following cesarean delivery. However, with respect to postpartum hemorrhage, severe postpartum hemorrhage, mean estimated blood loss and adverse effects, our analysis failed to detect a significant difference. Studies comparing carbetocin with syntometrine in women undergoing vaginal delivery demonstrated no statistical difference in terms of risk of postpartum hemorrhage, severe postpartum hemorrhage or the need for additional uterotonic agents, but the risk of adverse effect was significantly lower in the carbetocin group. CONCLUSIONS:
|
Authors | Bohong Jin, Yongming Du, Fubin Zhang, Kemei Zhang, Lulu Wang, Lining Cui |
Journal | The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
(J Matern Fetal Neonatal Med)
Vol. 29
Issue 3
Pg. 400-7
( 2016)
ISSN: 1476-4954 [Electronic] England |
PMID | 25579116
(Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)
|
Chemical References |
- Oxytocics
- Oxytocin
- carbetocin
|
Topics |
- Female
- Humans
- Oxytocics
(therapeutic use)
- Oxytocin
(analogs & derivatives, therapeutic use)
- Postpartum Hemorrhage
(drug therapy)
- Pregnancy
- Randomized Controlled Trials as Topic
|